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V14 invariant (V14i) NKT cells are a sub­
set of mouse T cells that have been implicated 
in many immune and inflammatory responses, 
including  the  regulation  of  antimicrobial  re­
sponses, the balance between tolerance and auto­
immunity, and even inflammatory processes 
such as intestinal adhesions after viral infection, 
ischemia reperfusion injury, and the formation 
of atherosclerotic plaques (Godfrey et al., 2004; 
Lappas et al., 2006; Tupin et al., 2007; Kosaka 
et al., 2008). As the name implies, V14i NKT 
cells express a limited TCR repertoire, featuring 
an invariant V14­J18 TCR  chain usually 
paired with diverse V8.2, V7, or V2 chains. 
These cells recognize lipid antigens presented 
by CD1d, a class I–like antigen­presenting 
molecule, and they can therefore be precisely 
identified by tetramers of CD1d loaded with  
galactosyl ceramide (GalCer), a potent glyco­
lipid agonist. A homologous population of cells 
also exists in humans, which mostly express the 
human orthologues of the V14i/V8.2 TCR, 
namely an invariant V24 with a more diverse 
V11. Moreover, invariant NKT cells from 
humans and mice exhibit interspecies cross­
  reactivity, in that mouse V14i NKT cells can 
respond  to  glycolipids  presented  by  human 
CD1d, and vice versa, indicating conservation 
of this specificity (Brossay et al., 1998a; Kjer­
Nielsen et al., 2006).
V14i NKT cells are further characterized 
by their innate­like behavior. They constitu­
tively express cell surface proteins also found 
on NK cells and activated or memory T cell 
populations,  such  as  NK1.1  and  CD69,  and 
they rapidly secrete both Th1 and Th2 cyto­
kines in response to antigen without priming. 
The activated phenotype of these cells is im­
printed during thymic differentiation, suggest­
ing that they could be selected and/or expanded 
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Mouse natural killer T (NKT) cells with an invariant V14-J18 rearrangement (V14 
invariant [V14i] NKT cells) are either CD4+CD8 or CD4CD8. Because transgenic mice 
with forced CD8 expression in all T cells exhibited a profound NKT cell deficit, the absence 
of CD8 has been attributed to negative selection. We now present evidence that CD8 does 
not serve as a coreceptor for CD1d recognition and that the defect in development in CD8 
transgene homozygous mice is the result of a reduction in secondary T cell receptor  
rearrangements. Thymocytes from mice hemizygous for the CD8 transgene have a less severe 
rearrangement defect and have functional CD8+ V14i NKT cells. Furthermore, we demon-
strate that the transcription factor Th, Poxviruses and Zinc finger, and Krüppel family  
(Th-POK) is expressed by V14i NKT cells throughout their differentiation and is necessary 
both to silence CD8 expression and for the functional maturity of V14i NKT cells. We 
therefore suggest that Th-POK expression is required for the normal development of V14i 
NKT cells and that the absence of CD8 expression by these cells is a by-product of such expres-
sion, as opposed to the result of negative selection of CD8-expressing V14i NKT cells.
© 2010 Engel et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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NKT cells, as well as for the full functional response of this 
cell subset. Collectively, our data suggest that CD8 expres­
sion is excluded from the V14i NKT cells as a by­product 
of the expression of factors required for the developmental 
program of this population.
RESULTS
CD8 expression does not enhance V14i NKT cell responses
We previously performed surface plasmon resonance studies 
to identify an interaction between CD8 and the thymus leu­
kemia antigen, a nonclassical class I molecule (Fisher et al., 
1985; Leishman et al., 2001). Experiments performed in paral­
lel failed to convincingly demonstrate binding of CD8 even to 
CD1d tetramers (unpublished data). However, because there 
could be biologically meaningful interactions close to or below 
the level of detection, we focused our efforts on in vitro and 
in vivo functional assays to determine if the expression of CD8 
affects the antigen response of V14i NKT cells. Initially, ret­
roviruses were used to direct the expression of CD8 and 
CD8 chains in three mouse V14i NKT cell hybridomas. 
The 1.2 and 3.C3 cells express a TCR with V8.2  chains 
having different CDR3 regions, whereas the 1.4 TCR utilizes 
an atypical V10 polypeptide (Burdin et al., 1998). Cells ex­
pressing near physiological levels of CD8 were selected by 
magnetic and flow cytometric cell sorting (Fig. 1 A and not 
depicted). We also established control hybridoma sublines 
transduced with empty retrovirus vector, and we compared 
the CD8­expressing V14i NKT cell hybridomas with the 
controls for IL­2 production in response to thymocytes pulsed 
with the synthetic antigen GalCer, a potent agonist related to 
the antigens found in Sphingomonas bacteria. Antigen­pulsed 
CD1d transfectants of the B cell lymphoma A20 and bone 
marrow–derived DCs were also tested as APCs. Furthermore, 
to allow for the possibility that CD8 expressed by the hy­
bridomas might bind to classical class I molecules on the APC, 
providing an adhesion function separate from a true corecep­
tor function, we also tested the hybridomas in an APC­free 
system with GalCer presented by plate­bound CD1d pro­
tein. If CD8 acted as a TCR coreceptor, we would expect a 
shift in the antigen dose response curve as a result of enhanced 
antigen sensitivity mediated by CD8. However, we did not 
find a consistent difference between the CD8­expressing   
hybridomas and empty vector control transductants in their   
antigen response (Fig. 1 B and not depicted), even at GalCer 
concentrations as low as 2 ng/ml. Similar experiments using 
the Sphingomonas­derived glycolipid GalA­GSL, a less potent 
agonist, also failed to find any effect of CD8 expression on the 
antigen response (unpublished data).
We also measured the effect of CD8 expression on the 
avidity  of  the  1.2  and  1.4  hybridoma  lines  for  GalCer­
loaded CD1d (GalCer­CD1d) tetramers by staining the 
CD8­expressing and control lines with serial dilutions of   
tetramers and determining the fluorescence intensity via flow 
cytometry. The resulting tetramer isotherm analyses revealed 
that CD8 expression had little or no effect on GalCer­
CD1d tetramer avidity (Fig. S1). Similar experiments using 
in the thymus by self­agonists (Bezbradica et al., 2006). It is 
therefore not surprising that the thymic selection of V14i 
NKT cells exhibits several unique requirements. Notable 
among these is the need for the adaptor SAP acting down­
stream of SLAM family receptors and positive selection me­
diated by double­positive (DP) thymocytes (Kronenberg and 
Engel, 2007). Upon the initiation of the V14i NKT cell 
developmental program, CD8 is down­regulated, and later 
during their maturation a fraction of these cells lose CD4 
expression as well, such that mature V14i NKT cells are   
either CD4 single positive (SP) or double negative (DN) 
but never CD8 SP. They share this pattern of expression   
with other unconventional TCR + lymphocytes, including 
CD1d­reactive cells with more diverse TCRs, and cells not 
reactive to CD1d, such as MAIT (mucosal­associated invariant 
T cell). In contrast, a fraction of human V24i NKT cells 
express CD8; however, this is predominantly CD8, and 
the acquisition of CD8 expression occurs largely after matu­
ration in the thymus is complete (Loza et al., 2002; Godfrey 
et al., 2004; Berzins et al., 2005).
The mechanisms underlying the absence of CD8 SP 
lymphocytes in V14i NKT cells and other unconventional 
TCR + lymphocytes are not known. Pioneering studies 
found that mice with a transgene that enforced the expression 
of CD8 throughout the T cell lineage lacked NKT cells, 
defined in part in those early studies as cells coexpressing 
NK1.1 and TCR­ (Lantz and Bendelac, 1994; Bendelac, 
1995). Furthermore, the V repertoire of NKT cells from 
CD8­deficient mice was subtly altered, and CD8 SP T cells 
from V14i transgenic mice exhibited a selective depletion 
of the V8 and V7 chains most commonly expressed by 
mouse V14i NKT cells (Bendelac et al., 1996). These data 
led to the conclusion that CD8+ V14i NKT cells were 
eliminated via negative selection. This hypothesis, together 
with subsequent studies demonstrating that V14i NKT cells 
were self­reactive to CD1d, suggested that CD8 might inter­
act with CD1d as a coreceptor, which is similar to its interac­
tion with classical MHC class I molecules (Bendelac et al., 
1995). Indirect evidence using cells overexpressing CD1d 
was also consistent with a CD1d–CD8 interaction (Teitell   
et al., 1997). Therefore, according to this view, the positive 
selection of V14i NKT cells by self­agonists may put them 
close to the threshold of negative selection, with the coen­
gagement of CD8 pushing them over the line. Co­receptor 
expression by V14i NKT cells and selection by self­agonists 
fit nicely with hypotheses attributing CD4 expression in con­
ventional T cells to enhanced lck signal strength or prolonged 
kinetics of signaling (Singer et al., 2008), although the selec­
tion of V14i NKT cells by self­agonists remains unproven.
In this paper, we report on experiments that examine the 
mechanisms by which CD8 expression is excluded from the 
V14i NKT lineage. We conclude that CD8+ V14i NKT 
cells are not eliminated by negative selection. Instead, we 
find roles for the transcription factor Th, Poxviruses and 
Zinc­finger (POZ), and Krüppel family (Th­POK) in enforc­
ing the expression of CD4, as opposed to CD8 on V14i JEM VOL. 207, May 10, 2010 
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Effect of CD8 deficiency on the V repertoire
We examined if CD8 normally acts to modulate V14i NKT 
cell differentiation. CD8­null mice were previously reported 
to contain elevated fractions of V7+ NKT cells, (Bendelac 
et al., 1994), suggesting that CD8 plays a role in shaping the 
V repertoire of V14i NKT cells. Subsequent results from 
other studies suggested that V14i TCRs containing V7 
have a higher affinity for endogenous ligands presented by 
CD1d and, therefore, the increase in V7­expressing cells in 
the absence of CD8 is consistent with a partial release from 
negative selection (Chun et al., 2003; Schümann et al., 2006; 
Wei et al., 2006). Precise identification of V14i NKT cells 
was difficult at the time these earlier studies were performed, 
however, because CD1d tetramers were not available.
We stained thymocytes from CD8­null and WT mice 
with GalCer­CD1d tetramers together with antibodies 
against V2, V7, and V8.1/8.2. We observed no signifi­
cant difference between the V repertoires of V14i NKT 
thymocytes from CD8­deficient and WT mice (Table I), 
suggesting that CD8 expression normally does not modulate 
the selection of V segments by V14i NKT cells.
Expression of CD8 by V14i NKT cells in transgenic mice
The observations in the previous sections led us to reexamine 
if the development of V14i NKT cells is affected by en­
forced expression of CD8 in the T cell lineage. We therefore 
obtained and analyzed the same CD8 transgenic line that was 
examined in earlier studies (Robey et al., 1991; Bendelac   
et al., 1994). In these mice, CD8 and  expression is con­
trolled by enhancer and promoter sequences derived from 
the CD2 gene (Robey et al., 1991). Thymus, spleen, and 
liver cell suspensions prepared from CD8 transgenic and WT 
mice were stained with GalCer­CD1d tetramers together 
with a mix of antibodies to define V14i NKT cells and 
other subsets. In agreement with the original study, we found 
that mice homozygous for the CD8 transgene (CD8 Tg/Tg) 
exhibited markedly reduced (>10­fold) numbers of V14i 
NKT cells in both the thymus and periphery (Fig. 2). Sur­
prisingly, mice that were hemizygous for the CD8 transgene 
(CD8 Tg/+) had significant populations of V14i NKT cells, 
although the numbers were approximately two­ to threefold 
lower than those in WT littermates (Fig. 2). Some of the 
V14i NKT cells that expressed CD8 also coexpressed CD4, 
although the percentage of DN V14i NKT cells was in­
creased compared with WT mice (Fig. 2 A).
V14i NKT development in the thymus is characterized 
by the successive induction of high levels of CD44 followed by 
NK1.1 (Benlagha et al., 2002). Mutations that disrupt NKT 
development could cause a block in the transition from   
CD44low NK1.1low (stage 1) to CD44high NK1.1low (stage 2) or 
from stage 2 to CD44high NK1.1high (stage 3), and hence result 
in higher percentages of stage 1 or stage 2 NKT cells. To   
determine whether enforced CD8 expression arrested NKT 
development at either stage 1 or 2, we assessed the expression 
of CD44 and NK1.1 on V14i NKT thymocytes from CD8 
transgenic and nontransgenic littermates. The fractions of NKT 
CD1d tetramers loaded with the less potent GalCer analogue 
 glucosyl ceramide also did not reveal any effect of CD8 ex­
pression on antigen avidity (unpublished data).
Figure 1.  Unaltered response to GalCer by CD8 expressing V14i 
NKT cell hybridomas. (A) CD8 expression in V14i NKT cell hybridomas 
1.2 (left) and 1.4 (right) after transduction with CD8 and CD8 retroviral 
constructs and selection for expression of CD8 and TCR. Top, staining with 
anti-CD8; bottom, staining with anti-CD8. Solid black lines, hybridoma 
transduced with CD8 and CD8 retroviral constructs; gray lines, TCR-+ 
CD8SP splenocytes; dotted lines, hybridoma transduced with empty vec-
tor retroviral construct. (B–D) Hybridomas were cultured in the presence 
of thymocytes (B) or A20.CD1d cells (C) pulsed with 2, 20, or 200 ng/ml of 
GalCer, or plates coated with recombinant mouse CD1d with 2, 20, or 
200 ng/well of GalCer (D), and supernatants collected after overnight 
culture were assayed for IL-2 by ELISA. The amounts of IL-2 produced by 
hybridomas stimulated by APCs or recombinant CD1d not incubated with 
GalCer were below the detectable levels in these experiments (not de-
picted). Data are representative of at least two independent experiments.1018 Why iNKT cells don’t express CD8 | Engel et al.
to antigen administered in vivo, as measured by intracellular 
cytokine staining (Fig. 3 and not depicted). Thus the expres­
sion of CD8 had no apparent effect on the in vivo antigen 
response of V14i NKT cells.
Effect of CD8 on V14i NKT cell TCR avidity
If CD8 acted as a coreceptor when expressed by V14i NKT 
cells, it would be predicted to increase the avidity and to   
decrease the TCR off rate for cognate antigen (Garcia et al., 
1996). We therefore examined if CD8 increased V14i 
NKT cell antigen avidity by comparing CD8 transgenic and 
WT V14i NKT cells in two different CD1d tetramer bind­
ing assays. An equilibrium binding or tetramer binding iso­
therm analysis was performed by mixing WT and CD8 Tg/+ 
thymocytes and by staining aliquots with serial dilutions of 
GalCer­CD1d tetramers, followed by staining with anti­
bodies against CD8 and other T cell surface markers that   
permit unambiguous identification of V14i NKT cells. We 
also measured the tetramer off rates from WT and CD8 
transgenic V14i NKT cells by determining the decrease in   
GalCer­CD1d tetramer mean fluorescence intensity after 
incubation of stained aliquots at 37°C. We could not detect 
any effect of CD8 expression on V14i NKT cell antigen 
avidity or the off rate (Fig. S3).
Effects of the CD8 Tg on V14i NKT T cell V gene 
repertoire and CD1d expression
The modulation of CD1d expression by thymocytes can affect 
NKT cell V repertoire, with changes in CD1d levels corre­
lating inversely with the fraction of V14i NKT cells express­
ing V7 (Chun et al., 2003; Schümann et al., 2006; Wei et al., 
2006). These data suggest that V7 usage is enhanced under 
conditions of reduced antigen avidity. We thus examined the 
fraction of cells expressing V7 and V8.1/8.2 in CD8+ 
V14i NKT cells from CD8 Tg/+ mice. The CD8+ V14i 
NKT cell populations in the thymus contained an increased 
fraction of cells expressing V7 (Fig. S4), which would be the 
opposite of expectation if CD8 expression enhanced the avid­
ity of V14i NKT cells for endogenous ligands. Breeding the 
CD8 transgene onto a Kb and Db­null background had no in­
fluence on the increased V7 expression by V14i NKT thy­
mocytes from CD8 Tg mice (unpublished data; Vugmeyster 
et al., 1998). These findings indicate that the CD8 transgene 
could modulate V14i NKT cell selection through a mecha­
nism independent of its ability to interact with classical MHC 
class I antigen­presenting molecules but in a manner appar­
ently inconsistent with CD8 coreceptor function.
cells in stages 1, 2, and 3 in either CD8 hemizygous or homo­
zygous transgenic mice were similar to those of nontransgenic 
littermates, suggesting that expression of CD8 did not affect 
the developmental transition from stage 1–3 (Fig. 2 A).
The influence of CD8 transgene copy number on V14i 
NKT cell differentiation suggested the possibility that there 
was a threshold level of CD8 beyond which V14i NKT cell 
development was nearly completely inhibited. Thus, it was 
important to compare the levels of CD8 expressed in CD8 
Tg/+ mice to those expressed by WT CD8+ SP thymocytes 
and mature T cells. We measured the anti­CD8 median   
fluorescence intensity (MFI) observed in WT SP CD8+  
thymocytes, mature CD8+ T cells, and V14i NKT cells and 
conventional T lymphocytes from CD8 transgenic mice. We 
determined the number of anti­CD8 binding sites by inter­
polation of the MFI from each population against a standard 
curve prepared by staining beads with defined numbers of 
antibody binding sites. An analogous approach was also used 
to measure the numbers of anti­CD4 binding sites in CD4+ 
V14i NKT cells and conventional CD4+ T lymphocytes. 
We found that the numbers of both anti­CD8 and anti­
CD8 binding sites on mature (TCRhigh) CD4+ thymocytes 
and CD4+ peripheral T cells in CD8 Tg/+ mice were similar 
to those observed in WT CD8+ SP thymocytes and T cells 
(Fig. S2 and not depicted). V14i NKT cells from CD8 
Tg/+ mice were found to express levels of both CD8 and 
CD8 that were approximately half of those observed in WT 
CD8+ SP thymocytes and T cells (Fig. S2 and not depicted). 
However, a similar reduction in the amount of CD4 was also 
observed in CD4+ V14i NKT cells from either WT or CD8 
transgenic animals as compared with WT CD4+ SP thymo­
cytes and T cells (Fig. S2). These data demonstrate that the 
CD8 transgene construct drove expression levels in transgene 
hemizygous T cells that appeared physiologically appropriate. 
Furthermore, they suggest that the lower CD8 amounts   
observed in V14i NKT cells from CD8 Tg/+ mice might 
be attributable to general mechanisms that normally act to 
down­regulate CD4, and perhaps also expression of the 
TCR, in V14i NKT cells.
We  examined  the  response  of  CD8  Tg/+  mice  to 
GalCer administered in vivo to determine if CD8 expression   
affected V14i NKT cell function. Spleen and liver cell   
suspensions, together with serum samples, were prepared   
90 min after GalCer injection. The cell suspensions were 
stained to identify V14i NKT cells, followed by intracellu­
lar staining for IFN­, IL­4, and TNF. We observed no dif­
ference in the response of CD8+ and WT V14i NKT cells 
Table I.  Effect of CD8 deletion on V14i NKT thymocyte and V repertoire
Strain V14i NKT cells that express V2 V14i NKT cells that express V7 V14i NKT cells that express V8.1/8.2
% % %
C57BL/6 (n = 6) 14 ± 4 15 ± 4 70 ± 2
Cd8a/ (n = 6) 11 ± 1 16 ± 3 67 ± 5
Fold change in KO versus WT 0.8 1.1 1.0JEM VOL. 207, May 10, 2010 
Article
1019
Figure 2.  V14i NKT cells in CD8 transgenic mice. (A) Flow cytometric analysis of thymocytes from (top) WT mice, mice homozygous for the CD8 
transgene (CD8 Tg/Tg; middle), and CD8 Tg hemizygous mice (CD8 Tg/+; bottom). The first column shows anti–TCR- and GalCer-CD1d tetramer  
staining, the second column shows V14i NKT cells, defined as gated in the left column, stained for CD4 and CD8, the third column shows CD4 and 
CD8 staining of total thymocytes, and the fourth column shows the staining of V14i NKT thymocytes for NK1.1 and CD44, which was used to  
determine the percentages of cells within the stage 1 (CD44low, NK1.1low, bottom left box), stage 2 (CD44high, NK1.1low, top left box) and stage 3 (CD44high, 
NK1.1high, right box) V14i NKT developmental subsets. Data are representative of at least nine independent experiments. (B) Flow cytometric analysis  
of liver mononuclear cells (LMCs) obtained from the indicated mice stained with GalCer-CD1d tetramers together with antibodies against TCR- and 
CD8. The left column shows staining with GalCer-CD1d tetramers and anti–TCR- to define the V14i NKT and conventional T subsets, with CD8 
staining depicted for V14i NKT cells (middle column) and conventional T cells (right column). Data are representative of more than six independent  
experiments. (C) Scatter plot of the number of V14i NKT cells observed in thymus, spleen, and livers of CD8 Tg/+ and WT littermate mice. Matching symbol 
styles represent numbers determined from littermates on the same day. Paired Student’s t test p-values are shown, with significant differences indicated 
by asterisks (**, 0.001 ≥ P ≤ 0.01; ***, P < 0.001). Error bars show SD and horizontal bars show the arithmetic mean of the samples in each column.1020 Why iNKT cells don’t express CD8 | Engel et al.
the CD8 Tg homozygotes expressed less CD1d than either 
strain (unpublished data). These data implied that the effect of 
the CD8 Tg on the V14i NKT TCR V repertoire was, at 
least in part, the result of an unanticipated reduction in CD1d 
expression by DP thymocytes in these mice, and they suggest 
that the effect of increased levels of CD8 in the Tg homozy­
gous mice had an additive effect on CD1d expression.
Decreased thymocyte survival in CD8 Tg mice
The CD8 Tg mouse line used in this and the earlier study 
(Bendelac et al., 1994) is known to exhibit defects in thymo­
cyte maturation (Wack et al., 2000). We therefore performed 
experiments to test if the deficit in V14i NKT cells in CD8 
Tg homozygotes could be related to the more general defects 
in thymocyte development, as opposed to self­ligand–mediated 
negative selection. As previously reported (Wack et al., 2000), 
the transition from the DN to the DP stages is partially inhib­
ited in thymocytes from the CD8 Tg line, which was reflected 
both by increases in the fractions of DN and immature SP 
thymocytes and by decreases in the fraction of DP thymo­
cytes and overall thymocyte cellularity (Fig. 4, A and B; and 
not depicted). Furthermore, we found that the severity of 
these maturation defects was much more pronounced in mice 
that were homozygous for the CD8 transgene (Fig. 4, A and 
B; and not depicted).
Thymus hypocellularity can be attributed to defects either 
in thymocyte expansion or survival. To determine if thymo­
cyte survival is perturbed in CD8 Tg mice, we used ex vivo 
cultures. DP thymocytes from CD8 Tg/Tg mice exhibited a 
markedly reduced viability in culture compared with either 
Tg/+ or WT littermates (Fig. S6 A). These data suggest that 
the lifespan of DP thymocytes in vivo in CD8 Tg/Tg mice 
was likely to be compromised, which could account for the 
more than fivefold decrease in total thymocyte number. Addi­
tionally, we observed that CD8 Tg/Tg DP thymocytes had 
lower TCR expression and higher forward light scatter than 
hemizygous and nontransgenic littermates (Fig. S6, B and C). 
These phenotypes suggest that CD8 Tg/Tg DP thymocytes 
had a higher fraction of relatively immature cells, and they are 
consistent with, although they do not formally demonstrate,   
a survival defect within the more mature DP subset.
Preferential J rearrangement in CD8 Tg mice
Mutations that restrict DP thymocyte lifespan are known to 
cause severe reductions in the development of V14i NKT 
cells (Bezbradica et al., 2005; Egawa et al., 2005). This has 
been attributed to the fact that gene rearrangement within the 
TCR­ locus proceeds in an ordered fashion, with recombi­
nation beginning at the 5 or V proximal end of the J clus­
ter, and then progressing in a 3 or distal direction via secondary 
 rearrangements that occur during thymocyte maturation 
(Yannoutsos et al., 2001). Because the canonical V14­J18 
rearrangement utilizes a J element near the 3 end of the J 
locus, V14i NKT cell development is highly dependent   
on these secondary rearrangements that are decreased when   
DP thymocyte survival is impaired. We therefore performed   
The effect of the CD8 transgene on the V14i NKT cell 
TCR V repertoire was similar to that observed in mice with 
reduced levels of thymocyte CD1d expression (Schümann   
et al., 2006; Wei et al., 2006). These observations led us to 
examine CD1d expression by cells from CD8 Tg mice. We 
found no differences in the amount of CD1d between CD8 
Tg/+ and WT mice in mononuclear cells obtained from the 
spleen or liver (not depicted) or in mature TCRhigh thymo­
cytes (Fig. S5 A). In contrast, we found that CD1d expression 
in TCRlow DP thymocytes from CD8 Tg hemizygotes was 
reduced, with the MFI obtained by anti­CD1d staining only 
60% of that observed in nontransgenic littermates (Fig. S5). 
The CD1d staining intensity of the TCRlow DP thymocyte 
subset  in  CD8  Tg/Tg  mice  was  reduced  even  further  to 
30% of the level of WT (Fig. S5 B and not depicted). The 
amount of CD1d expression by the CD8 Tg/+ mice was not 
much greater than that expressed by Cd1d+/ mice, whereas 
Figure 3.  Response of CD8 Tg V14i NKT cells to antigen in vivo. 
CD8 Tg/+ and WT littermate mice were injected i.p. with 2 µg GalCer. Mice 
were killed 90 min later, and liver and spleen cell suspensions were prepared 
and stained with GalCer-CD1d tetramers and additional antibodies to 
define V14i NKT cells. Depicted is the intracellular staining of V14i NKT 
cells from GalCer-challenged mice with anti-IFN (A) and anti–IL-4  
(B) mAbs as compared with the staining of V14i NKT cells from mock-
challenged mice. Data are representative of four independent experiments.JEM VOL. 207, May 10, 2010 
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from mice homozygous for the CD8 transgene, reductions   
in the very distal J gene segments were observed even in 
CD8 Tg/+ mice (Fig. 4 C). These data demonstrate that the 
CD8 transgene induced a general defect in rearrangement 
to the distal end of the J locus, and they imply that the inhi­
bition of V14i NKT cell development in CD8 Tg/Tg mice 
is not a result of antigen receptor specificity but rather of a   
reduction in the frequency of rearrangements necessary for 
the expression of the V14i TCR.
A V14i transgene rescues NKT development  
in CD8 Tg homozygous mice
To confirm that the decrease in V14i NKT cells in CD8 
Tg/Tg mice is the result of a J re­
arrangement defect, we circumvented 
the putative gene rearrangement road 
block  by  generating  mice  that  were   
homozygous  for  the  CD8  transgene 
and also carried a transgene that en­
forced expression of a rearranged V14i 
TCR­ chain in all T cells (Bendelac 
multiplex PCR analysis to assess the relative frequency of   
rearrangement between V14 and both proximal and distal   
J elements. Rearrangement events between V14 and J   
elements near the proximal end of the J locus were readily 
detectable in all of the thymus samples regardless of the pres­
ence of CD8 transgene (Fig. 4 C). The canonical V14­J18 
rearrangement was dramatically reduced in CD8 Tg/Tg (Fig. 
4 C), but not in CD8 Tg/+ thymocyte DNA, which fits with 
the low frequency of V14i NKT thymocytes in homozy­
gotes and near normal numbers in CD8 Tg/+ mice. How­
ever,  CD8  Tg  thymocytes  exhibited  lower  frequencies  of 
rearrangement events between V14 and all distal J elements 
assessed. Although this was particularly evident in thymocytes 
Figure 4.  Effect of the CD8 transgene on 
thymocyte differentiation. (A) Decreased 
total thymocytes. Scatter plot depicting total 
thymocytes from six independent littermate 
groups, each containing one nontransgenic, 
one CD8 Tg/+, and one or two CD8 Tg/Tg 
mice. Littermates analyzed on the same day 
are represented by identical symbols. Paired 
Student’s t test p-values are shown, with 
significant differences indicated by asterisks 
(***, P < 0.001). (B) Decreased DP thymocytes. 
CD4 and CD8 staining of thymocytes from 
two CD8 Tg/Tg mice along with littermates 
that were either CD8 Tg/+ or nontransgenic 
littermate controls (NLCs). The antibody used 
against CD8.2 detects only the endogenous 
CD8 allele. (C) Decreased distal J rearrange-
ments. Genomic DNA prepared from thymo-
cytes from a CD8 Tg/+ mouse, a littermate 
control (NLC), and two CD8 Tg/Tg mice, as  
well as Rag/ splenic DNA, was amplified  
in separate reactions with primers specific for 
V14 and four different J segments from 
either the proximal or distal region of the J 
locus. Samples of each reaction were sub-
jected to agarose gel electrophoresis and ana-
lyzed by Southern blotting. Rearrangement 
products were identified by hybridization with 
a 32P-labeled V14 probe. Numbers designate 
bands resulting from rearrangement of V14 
to the indicated J elements, and the proxim-
ity of the J segments allows the detection of 
several bands with one primer. All data in this 
figure are representative of at least three 
independent experiments.1022 Why iNKT cells don’t express CD8 | Engel et al.
cells, and Th­POK–null thymocytes expressing TCRs that 
would normally promote positive selection to a CD4 SP lin­
eage are instead redirected to a CD8 SP fate (Keefe et al., 1999; 
He et al., 2005). Th­POK has also been shown to repress CD8 
expression by conventional CD4 peripheral T cells (Wang et al., 
2008). Moreover, enforced expression of Th­POK changes 
the fate of thymocytes selected by classical MHC class I mole­
cules from CD8 SP to CD4 SP (He et al., 2005; Sun et al., 
2005). There is no evidence, however, that Th­POK has ef­
fects on the negative selection of T lymphocytes.
We examined whether a deficiency in Th­POK affected 
V14i NKT cells by phenotypic analysis of mice homozy­
gous for the spontaneous helper deficient (hd) mutation in the 
Th­POK gene (Dave et al., 1998; He et al., 2005). We found 
that the numbers and percentages of V14i NKT cells in   
hd/hd mice were similar to those in WT or hd/+ littermates 
(Fig. 6, A and B). Interestingly, the mature V14i NKT cells 
from hd/hd mice were either CD8 SP or DN, with the ratio 
of CD8 SP to DN similar to the CD4/DN ratio observed in 
mice WT for Th­POK (Fig. 6 C). These data demonstrate 
that Th­POK is required for the differentiation of both CD4 
SP V14i NKT and conventional T cells but not for the 
generation of DN V14i NKT cells, although there is evi­
dence that these T lymphocytes are derived from a CD4+ 
precursor (Benlagha et al., 2005).
Th-POK is required for V14i NKT cell function
Although V14i NKT cells from hd/hd mice exhibited no 
defects  in  the  expression  of  surface 
antigens such as CD44 and NK1.1, 
we did find that they expressed ab­
normally low levels of the activation 
marker CD69 (Fig. 7 A). These data 
suggested  that  hd/hd  V14i  NKT 
et al., 1996). Analyses of these V14i Tg + CD8 Tg/Tg mice 
demonstrated that the introduction of the V14i transgene re­
sulted in the generation of large numbers of GalCer­CD1d 
tetramer­binding T cells and that a substantial portion of these 
cells exhibited a CD44high NK1.1high surface antigen pheno­
type that is characteristic of mature WT V14i NKT cells 
(Fig. 5 A). Furthermore, V14i NKT cells from V14i Tg + 
CD8 Tg/Tg double transgenic mice made a robust response 
to GalCer stimulation in vivo, with equivalent IFN­ syn­
thesis and only slightly decreased IL­4 synthesis compared 
with V14i Tg mice hemizygous for the CD8 Tg (Fig. 5 B). 
These data confirm that thymocytes in CD8 Tg homozygotes 
expressing the V14i NKT TCR are not subject to negative 
selection and, furthermore, that the reduced amount of CD1d 
expressed by CD8 Tg/Tg thymocytes is sufficient to promote 
V14i NKT cell differentiation.
Th-POK is required for the differentiation of CD4+ V14i 
NKT cells
To determine why V14i NKT cells do not normally assume 
a CD8 SP fate, we explored the possibility that differentiation 
of the V14i NKT cell lineage might involve the expression of 
factors that inhibit CD8 expression. The Zbtb7b gene directs 
the expression of the Th­POK or c­krox protein, which is a 
member of the BTB­POZ family of Zn finger transcriptional 
repressors which is required for the development of conven­
tional CD4 SP T cells (He et al., 2005). Mice that lack expres­
sion of a functional Th­POK protein lack mature CD4 SP T 
Figure 5.  A V14i transgene rescues the 
development of V14i NKT cells in CD8 
Tg/Tg mice. (A) Flow cytometric analysis of 
the indicated electronically gated populations 
from the spleens of littermate controls, V14i 
Tg, CD8 Tg/Tg, and V14i Tg + CD8 Tg/Tg dou-
ble transgenic mice depicting the staining  
with GalCer-CD1d tetramers and anti–TCR-,  
as well as the staining of cells within the 
V14i NKT cell gate for CD44 and NK1.1. Data 
are representative of two separate experi-
ments involving five V14i Tg + CD8 Tg/Tg 
double transgenic mice and similar numbers 
of controls. (B) Flow cytometric analysis of 
intracellular cytokine expression by liver CD-
44high V14i NKT cells from V14i Tg + CD8 
Tg/Tg double transgenic, V14i Tg, and con-
trol WT mice analyzed ex vivo 90 min after 
injection of GalCer. Data are representative 
of three V14i Tg + CD8 Tg/Tg double trans-
genic V14i mice.JEM VOL. 207, May 10, 2010 
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function, although normal numbers of V14i NKT cells are 
generated in the hd mutant mice. Furthermore, the reduced 
response was not a direct consequence of CD8 expression 
by the mature cells because DN V14i NKT cells from   
hd/hd mice exhibited intracellular cytokine levels that were 
the same as or lower than those of the CD8+ subset (Fig. S7). 
However, it remained possible that very low levels of CD8 
expression were sufficient to render V14i NKT cells hypo­
responsive or that prior expression of CD8 partially anergized 
cells might have a maturation or activation defect. We there­
fore subjected hd/hd and WT control mice to in vivo chal­
lenge with GalCer. As assessed by intracellular cytokine 
staining and measurement of serum IL­4 levels, we found 
that hd/hd mice exhibited a markedly reduced in vivo re­
sponse to GalCer (Fig. 7, B and C). The decrease was 
strongest for IL­4 production but also involved TNF syn­
thesis and IFN­ to a lesser extent. These findings demon­
strate that Th­POK is required for full V14i NKT cell 
Figure 6.  Th-POK regulates CD4 and CD8 expression in V14i NKT cells. (A) Staining of thymocytes and electronically gated B220 splenocytes 
and liver mononuclear cells from hd/hd and +/+ littermates with Galcer-CD1d tetramers and anti–TCR-. The percentages of V14i NKT cells are indi-
cated next to the gates. Data are representative of at least five individual experiments. (B) Scatter plots depicting the numbers of V14i NKT cells ob-
served in the thymus (n = 6), spleen (n = 4), and liver (n = 3) of 6–10-wk-old hd/hd and hd/+ littermates. Different symbols are used to represent separate 
littermate pairs. Paired Student’s t test p-values are shown, with significant differences indicated by asterisks (*, 0.05 > P < 0.01). Error bars show SD and 
horizontal bars show the arithmetic mean of the samples in each column. (C) CD4 and CD8 expression in T cells from mice carrying the hd mutation in 
the Th-POK gene. Liver mononuclear cells from WT (+/+, left) and hd/hd mice (right) were stained with GalCer-CD1d tetramers together with antibodies 
against CD4, CD8, and TCR-. Plots shown depict the CD8 and CD4 expression in V14i NKT and conventional T cell populations (Conv T cells). Data are 
representative of at least six independent experiments.1024 Why iNKT cells don’t express CD8 | Engel et al.
Th-POK–mediated transcriptional regulation of cytokines  
in V14i NKT cells
Our data suggested that Th­POK might play a role in the in­
duction of cytokine transcription upon antigen recognition by 
V14i NKT cells. We therefore prepared liver mononuclear 
cell RNA from mice with or without WT Th­POK function 
that had been challenged by GalCer and measured the rela­
tive amounts of Il4 and Ifng transcripts by quantitative real­
time PCR analysis of cDNA generated from these preparations. 
In agreement with the intracellular cytokine staining data, the 
induction of Il4 transcripts by GalCer 
was dramatically reduced in Th­POK 
mutants, whereas the effect of Th­POK 
deficiency on Ifng transcript accumula­
tion was more modest (Fig. 8).
V14i NKT cells are distinguished 
by the constitutive expression of de­
tectable amounts of both Il4 and Ifng 
RNA in the absence of exogenous an­
tigen stimulation (Stetson et al., 2003). 
The presence of these transcripts is 
likely to be a reflection of the epigenetic 
DN V14i NKT cells. We thus crossed hd mutants with 
mice carrying a targeted deletion of the CD8 gene and 
measured  the  responses  of  hd/hd  CD8/  and  hd/hd 
CD8+/ V14i NKT cells to in vivo GalCer challenge 
by intracellular cytokine staining (Fung­Leung et al., 1991). 
The response of hd/hd NKT cells was not affected by their 
CD8 genotype (Fig. 7 D). These data indicate that the ef­
fects of Th­POK deficiency on the function of V14i NKT 
cells are independent of its role in repressing CD8 expres­
sion in these cells.
Figure 7.  Th-POK is necessary for the 
normal functional response of V14i  
NKT cells. (A) Reduced CD69 expression. 
Histograms depicting the expression of CD44, 
NK1.1, and CD69 on V14i NKT cells from  
the livers and spleens of hd/hd (red) and +/+ 
(blue) littermates, with the staining of WT  
CD8 SP T cells (green) overlain for compari-
son. Results are representative of at least six 
independent experiments. (B) Reduced IL-4 
production. Intracellular cytokine staining of 
V14i NKT cells from hd/hd and WT mice two 
h after injection of GalCer or vehicle. Liver 
and spleen cell suspensions were stained with 
GalCer-CD1d tetramers and anti–TCR-, 
after which cells were fixed, permeabilized, 
and stained with antibodies against IL-4 and 
IFN-. Data are representative of six indepen-
dent experiments. (C) ELISA was used to mea-
sure IL-4 in blood drawn from the indicated 
strains of mice injected 2 h previously with 
GalCer. Similar results were obtained in  
separate assays of two other sets of hd/hd 
and +/+ or hd/+ littermates challenged with 
GalCer (not depicted). (D) The functional 
effect of the hd mutation in V14i NKT cells 
is independent of CD8 expression. Staining  
for IL-4, IFN-, and TNF in permeabilized liver 
V14i NKT cells from mice with the indicated 
genotypes heterozygous or homozygous for 
the hd mutation and a disrupted CD8 allele. 
Cells were harvested 90 min after GalCer 
challenge. Similar responses were observed in 
a second pair of hd/hd, CD8/, and hd/hd 
CD8+/ littermates.JEM VOL. 207, May 10, 2010 
Article
1025
To examine Th­POK gene expression in V14i NKT cells, we 
analyzed Th-POKGFP/+ mice, in which the coding region of 
one allele of the Th­POK gene was replaced with sequence 
encoding GFP (Fig. 9; Setoguchi et al., 2008). Analysis of 
both the thymus and periphery of Th-POKGFP/+ mice re­
vealed that the intensity of GFP expression in the vast majority 
of V14i NKT cells was similar to that of conventional CD4 SP 
T cells, regardless of whether the V14i NKT cells were CD4 
SP or DN (Fig. 9). Qualitatively similar results were obtained 
when we analyzed CD4 SP and DN V14i NKT cells from 
F2F3 strain mice containing a Th­POK­GFP transgene (unpub­
lished data; He et al., 2008). Altogether, these data indicate that 
Th­POK is expressed by essentially all V14i NKT cells and that 
it is necessary for normal V14i NKT cell basal cytokine gene 
transcription and secretion by antigen­stimulated cells.
DISCUSSION
The regulation of CD4 and CD8 expression during thy­
mocyte maturation is largely dictated by the TCR coreceptor 
function of these molecules, as they participate in the recog­
nition of self­ligands presented by MHC class I or class II 
molecules, respectively. The roles, if any, of these corecep­
tors in the function of those TCR­+ T cell populations 
not selected by classical MHC class I or class II molecules are 
not as well understood. The initial characterizations of V14i 
NKT cells reported that they were absent from mice in which 
CD8 expression was enforced in T cells and, furthermore, 
that their V repertoire was altered in CD8­deficient mice 
structure of the Il4 and Ifng gene loci, which may contribute 
to the ability of these cells to produce cytokines rapidly upon 
exposure to antigen. To determine if Th­POK contributed 
to the expression of basal cytokine transcripts, we analyzed 
RNA  from  liver  mononuclear  cells  from  unstimulated   
mice that were highly enriched for V14i NKT cells. We 
found  that  Il4  transcripts  were  dramatically  reduced  in   
Th­POK mutant V14i NKT cells (Fig. 8). Basal Ifng tran­
scripts, in contrast, were only modestly affected by Th­POK 
mutation (Fig. 8).
Expression of Th-POK by V14i NKT cells
Our data suggest that V14i NKT cells normally express   
Th­POK, which might be required not only for the repres­
sion of CD8 expression but for their functional maturation. 
Figure 8.  Effect of Th-POK deficiency on cytokine gene transcrip-
tion in V14i NKT cells. (A and B) RNA analyzed was obtained from 
either liver mononuclear cells from the indicated mice that had been in-
jected with 2 µg GalCer (A) or mock-injected (not depicted) or from liver 
mononuclear cells from unstimulated mice from the same strains that had 
been highly enriched for V14i NKT cells by magnetic selection (B). cDNA 
was amplified with primers specific for the Il4 and Ifng loci using a real-
time thermocycler. Relative transcript quantities were normalized to L32 
and the fraction of V14i NKT cells in each preparation, as determined by 
flow cytometry. The bar graphs show data normalized to the amount from 
WT samples. Error bars indicate variation between duplicate or triplicate 
samples in one experiment. Data are representative of at least two experi-
ments testing independently collected samples. Injection of GalCer re-
sulted in a >100-fold increase in Il4 and Ifng transcripts (not depicted).
Figure 9.  Th-POK is expressed throughout V14i NKT cell differ-
entiation. Histograms depicting GFP reporter expression in V14i NKT 
and conventional T cell populations from the thymus, spleen, and liver of 
Th-POKGFP/+ mice. Similar data were obtained in at least four independent 
experiments on at least six mice.1026 Why iNKT cells don’t express CD8 | Engel et al.
(unpublished data). In contrast, the CD8 transgene does ap­
pear to affect the TCR repertoire of V14i NKT cells, in 
that  V14i  NKT  thymocytes  from  CD8  Tg  hemizygous 
mice have an elevated fraction of V7+ cells. These data 
might  suggest  that  the  expression  of  CD8  directly  affects   
the avidity of V14i NKT cells for selecting determinants,   
but contrary to the conclusions drawn from some previous 
studies, they imply that V7­expressing V14i NKT cells are 
more dependent, rather than less dependent, on the added 
avidity putatively provided by CD8. However, a second   
unexpected finding from the CD8 Tg mice, in addition to a 
reduced DP lifespan, is decreased CD1d expression by thy­
mocytes. We consider it likely that the changes in the V 
repertoire of V14i NKT cells observed in these mice are the 
result of reduced CD1d expression rather than CD8 mediat­
ing a coreceptor function or enhanced cell–cell interactions. 
This interpretation is consistent with studies showing that the 
fraction of V7+ V14i NKT cells correlated inversely with 
CD1d expression levels (Chun et al., 2003; Schümann et al., 
2006; Wei et al., 2006). Although CD1d expression is further 
reduced in CD8 Tg homozygotes as compared with CD8 Tg 
hemizygotes or CD1d+/ mice, the fact that introduction of 
a V14i transgene restores NKT development and function 
demonstrates  that  these  low  CD1d  levels  are  nevertheless   
sufficient to drive the differentiation of V14i NKT cells, 
and they point to the rearrangement defect as the principal 
cause of the NKT deficit in the CD8 Tg/Tg background.
V14i NKT cell development is uniquely dependent on 
a variety of receptors, signaling molecules, and transcription 
factors (Matsuda and Gapin, 2005). Recent studies of mice 
deficient for the nuclear high mobility group protein Tox 
have shown that this factor is required for the development 
of both conventional CD4+ T cells and the V14i NKT cell 
subsets (Aliahmad and Kaye, 2008), demonstrating a common 
genetic requirement for these two T lymphocyte subtypes. 
Our data reveal that the BTB­POZ zinc finger transcription 
factor Th­POK also has important roles in directing the dif­
ferentiation of both conventional CD4+ and V14i NKT 
cells. In Th­POK mutant mice, the differentiation of all CD4 
SP cells, including conventional and V14i NKT cells, is   
redirected toward a CD8 SP fate (He et al., 2005; Keefe et al., 
1999). Interestingly, in addition to CD8+ cells, a population 
of DN V14i NKT cells remains in these mice. Addition­
ally, our data indicate that Th­POK is expressed in all ma­
ture V14i NKT cells, whether they are CD4 SP or DN. 
Th­POK–deficient V14i NKT cells are hyporesponsive to 
antigenic stimulation. In WT mice, DN V14i NKT cells are 
highly responsive to stimulation with GalCer (Kronenberg   
and Gapin, 2002), and V14i NKT cells are also normal in 
CD4­deficient mice (Bendelac et al., 1994). In this manu­
script, we demonstrate that DN V14i NKT cells in the 
Th­POK mutant mice are as hyporesponsive as their CD8­
expressing counterparts and that deletion of the CD8 gene 
has no effect on the response of Th­POK–deficient V14i 
NKT cells to GalCer. Collectively, these data suggest that 
the functional defect in immune responses by V14i NKT 
(Bendelac et al., 1994; Lantz and Bendelac, 1994). These data 
led to the conclusion that differentiating NKT cells in the 
thymus that expressed CD8 were negatively selected, and 
they implied that CD8 acts as a CD1d coreceptor to increase 
the avidity of these cells for targets expressing the selecting 
glycolipid antigens. According to this view, the thymic self­
ligands for V14i NKT cells are of sufficient avidity that they 
are true TCR agonists or close to that level of affinity. There­
fore, they can positively select V14i NKT cells in the absence 
of a coreceptor, with CD8 coreceptor expression in fact caus­
ing their negative selection.
In this manuscript, however, we report that V14i NKT 
cells can develop and function in the context of enforced 
CD8 expression, and we demonstrate that CD8 has no ap­
parent effect on V14i NKT cell avidity for cognate antigen 
presented by CD1d. The negative effect of the CD8 Tg on 
the thymic differentiation of V14i NKT cells is not a result 
of negative selection, but is related to the effect of the trans­
gene on the normal developmental progression of all thymo­
cytes. The mouse line used in our studies was in fact previously 
shown to exhibit a reduced efficiency of early thymocyte 
maturation from the DN to DP stage (Wack et al., 2000), 
which we have also observed (unpublished data). The previ­
ous paper did not report any effects of the CD8 transgene 
on DP lifespan, however, and in fact demonstrated that a 
CD8 transgene construct that was not expressed until the DP 
stage had no effect on thymic cellularity. It is important to 
note, however, that all of the transgenic animals examined in 
the previous study were hemizygous for the CD8 trans­
genes. We also observed a much less dramatic phenotype in 
hemizygotes as compared with CD8 Tg homozygotes, in 
terms of the DP lifespan during in vitro culture, the accumu­
lation of DP thymocytes in vivo and overall thymus cellular­
ity, and the frequency of distal J rearrangements. Thus, our 
data collectively indicate that the CD8 transgene can   
affect at least two stages of thymocyte development but the 
effects of the transgene on DP thymocytes are much more 
apparent in homozygous animals. The mechanism for the   
developmental effect of the CD8 transgene on DP cell num­
ber is not known, and because the transgene overexpression 
is not physiological, we have not sought to determine the 
mechanism in this study of V14i NKT cell differentiation. 
We speculate, however, that the overexpression of CD8 
could lead to the sequestration of critical signaling molecules, 
such as the src family tyrosine kinase lck, away from TCR 
signaling complexes. Aberrant TCR signaling in mice homo­
zygous for the CD8 transgenes would then lead to a reduction 
in the DP thymocyte lifespan, with effects on rearrangement 
within the TCR­ locus that are the likely proximal cause of 
their V14i NKT cell deficiency.
The V14i NKT cells that are found in CD8 Tg/+ mice 
are functionally normal, as measured by intracellular cytokine 
expression  after  antigen  challenge  in  vivo.  In  addition,   
we have found no differences in the expression of CD69, 
NK1.1, or other NK and activation markers between V14i 
NKT cells from CD8 Tg/+ mice and nontransgenic littermates   JEM VOL. 207, May 10, 2010 
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Antigen  stimulation.  Thymocytes  (5  ×  106/ml)  or  A20.CD1d  cells   
(106/ml; Brossay et al., 1998b) were incubated with various concentrations   
of GalCer for 4 h at 37°C and then washed, resuspended at the same cell 
concentration, and added to 96­well flat­bottom tissue culture plates in a 
volume of 0.1 ml/well. Hybridomas (5 × 104/well) were added to wells in a 
volume of 0.1 ml, and cells were incubated overnight at 37°C. Stimulation 
with GalCer­loaded purified CD1d and ELISA assays were performed as 
previously described (Sidobre et al., 2002). In vivo antigen challenge was 
performed by injecting mice i.p. or i.v. with 2 µg GalCer dissolved in   
0.2 ml of PBS. Mice were killed 90–120 min after injection, at which time 
blood was drawn for serum cytokine analysis and spleen and liver mononu­
clear cell suspensions were prepared.
Antibodies, cell staining, and flow cytometry. R­phycoerythrin–
  conjugated and allophycocyanin streptavidin­CD1d tetramers loaded with 
GalCer were produced as previously described (Sidobre et al., 2002). Allo­
phycocyanin­conjugated  streptavidin­CD1d  tetramers  loaded  with  the 
GalCer analogue PBS57 were supplied by the National Institutes of Health 
Core Tetramer Facility. All antibodies were purchased from BD, eBioscience, 
or BioLegend. Flow cytometry was done using either a FACSCalibur or   
LSRII (BD), and data was analyzed using FlowJo software (Tree Star, Inc.). 
Intracellular cytokine staining was performed using a kit and protocol pur­
chased from BD. Primary mouse cell suspensions analyzed were obtained 
from mice between 6 and 10 wk of age.
Genomic rearrangement analysis. A multiplex PCR strategy to detect 
TCR­ rearrangements has already been described (Pasqual et al., 2002). 
Genomic DNA was isolated from thymocytes or RAG­deficient splenocytes 
using the DNeasy Blood and Tissue kit (QIAGEN) and was amplified using 
an upstream primer specific for the V14 gene segments paired in separate 
reactions with primers specific for J 2, 9, 16, 48, and 56. Each primer pair 
amplified the specific V14­J (x) rearrangement, as well as rearrangements 
to J gene segments within up to 5 kb upstream of the targeted J. DNA 
samples were also amplified with C primers as a positive control. PCR 
primers used in this study have been described previously (Mancini et al., 
2001; Pasqual et al., 2002; Hager et al., 2007). Amplifications were performed 
with Expand High­Fidelity Polymerase (Roche Applied Science) or Plati­
num Taq DNA Polymerase High Fidelity (Invitrogen) kits. Thermocycling 
conditions used were as previously described (Hager et al., 2007), except that 
the extension temperature was lowered to 68°C when the enzyme and kit 
were used (Invitrogen). PCR products were resolved on 1.4% agarose gels 
and blotted onto positively charged nylon membranes under alkaline condi­
tions. A V14­specific probe was generated by PCR amplification of plasmid 
DNA containing a V14i NKT TCR construct using the following primers: 
5­GGGAGAGAACTGCGTCCTTCAATGTA­3 and 5­AGATGTAG­
GTGGCAGTGTCATCCAG­3. The resulting PCR product was gel puri­
fied  and  labeled  with  32P­dCTP  by  random  oligonucleotide  priming, 
according to the DNA labeling systems kit and protocol (GE Healthcare). 
The resulting radiolabeled probe was used for Southern blot hybridization as 
previously described (Budowle and Baechtel, 1990).
Real-time PCR. For V14i NKT cell preparation, liver mononuclear cells 
were first incubated using biotinylated antibodies against CD19, CD45R, 
CD62L, TER­119, CD11b, CD24, F4/80, and Ly6G/Gr­1 (2 µg/ml 
each), and antibody­bound cells were removed using the EasySep system 
(Stem Cell Technologies). The remaining cells were then incubated with 
PE­CD1d tetramers loaded with GalCer (1:100 dilution) together with   
1 µg/ml of free streptavidin, and tetramer­binding cells were isolated us­
ing anti­PE microbeads and LS columns (Miltenyi Biotec). The cells were 
kept at 4°C after tetramer incubation until final isolation, at which point 
they were stored at 80°C. Purity as determined by flow cytometry was 
routinely 70% or greater. RNA was prepared using the RNeasy kit and 
protocol (QIAGEN). cDNA was prepared using the iScript kit and pro­
tocol (Bio­Rad Laboratories), and PCR reactions were performed using 
the Light SYBR 480 Master Mix (Roche). Cytokine gene transcript levels   
cells in the Th­POK mutant mice is not a direct consequence 
of either the absence of CD4 expression or the presence of 
CD8. Our data further suggest that factors such as Th­POK are   
expressed as a consequence of the activation of the V14i NKT 
cell developmental program. Because Th­POK is capable of 
repressing CD8, this implies that V14i NKT cells down­
regulate CD8 at least in part as a consequence of Th­POK 
expression (Wang et al., 2008). Furthermore, unexpectedly 
Th­POK is also required for the full functional maturation of 
these cells. Interestingly, another BTB­POZ family member, 
PLZF, has been recently shown to play a major role in speci­
fying the function of V14i NKT cells (Kovalovsky et al., 
2008; Savage et al., 2008). However, PLZF­deficient V14i 
NKT cells exhibit changes in surface antigen expression, tis­
sue distribution, and antigen response that are distinct from 
those in Th­POK mutants (Kovalovsky et al., 2008; Savage 
et al., 2008). Thus, it remains to be determined whether the 
structural similarities between Th­POK and PLZF bear any 
relation to the mechanisms underlying their diverse effects on 
V14i NKT development and function.
In conclusion, we provide strong evidence that the devel­
opment of CD8+ V14i NKT cells is not prevented by nega­
tive selection and that when CD8 expression is either forced 
or removed by genetic manipulation there is little effect on 
V14i NKT cell repertoire or function. Furthermore, our 
data suggest that the transcription factor Th­POK, expressed 
essentially throughout the V14i NKT developmental pro­
gram, is required for the normal function of these cells. As a 
by­product of this expression, they are CD8 negative and di­
rected to either a CD4 SP or DN fate.
MATERIALS AND METHODS
Mice. The CD8 Tg mouse line was obtained from cryopreserved storage 
at The Jackson Laboratory. Mice with targeted mutations in CD1d (Mendiratta 
et al., 1997) were provided by L. van Kaer (Vanderbilt University, Nashville, 
TN). CD8­deficient mice were purchased from The Jackson Laboratory 
(Fung­Leung et al., 1991). The hd/hd and Th­POKGFP mouse lines have 
been previously described (Keefe et al., 1999; Setoguchi et al., 2008). Mice 
with mutations in H­2Kb and H­2Db (Vugmeyster et al., 1998) were gifts 
from A. Sette (La Jolla Institute for Allergy and Immunology, La Jolla, CA). 
V14i transgenic mice (Bendelac et al., 1996) were obtained from A. Bendelac 
(University of Chicago, Chicago, IL). All mice, except for the Th­POKGFP 
line, had been backcrossed extensively onto a C57BL/6 background. Mice were 
housed under specific pathogen­free conditions and the experiments were in 
accordance with animal protocols approved by the Institutional Animal Care 
and Use Committees at the La Jolla Institute for Allergy and Immunology or 
the Fox Chase Cancer Center.
Retroviral-mediated  CD8  expression.  Full­length  cDNAs  encoding 
mouse CD8 and CD8 were subcloned into the retroviral vector MigRI 
(Pear et al., 1998). Transfection of the NX ecotropic retroviral packaging 
cell line and transduction of iNKT cell hybridomas were performed as previ­
ously described (Kinsella and Nolan, 1996; Engel and Murre, 1999). Trans­
duced lines were enriched for CD8+ cells by labeling with magnetic µ beads 
and passage over LS columns (Miltenyi Biotec) and selected for expression of 
near­physiological levels of CD8 by cell sorting with a FACSVantage SE 
(BD). TCR expression on transduced hybridoma lines was examined by flow 
cytometry before each GalCer stimulation assay, and magnetic enrichment 
or cell sorting was used when necessary to equalize TCR expression levels 
between CD8­expressing and empty vector–transduced lines.1028 Why iNKT cells don’t express CD8 | Engel et al.
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were normalized either to L32 transcript levels and the percentage of V14i 
NKT cells in each cell preparation or to V14­J18 transcript levels. Similar 
results were observed using either method of normalization. PCR primer   
sequences were as follows: Il4 forward, 5­ACAGGAGAAGGGACGC­
CAT­3;  Il4  reverse,  5­GAAGCCCTACAGACGAGCTCA­3;  Ifng   
forward, 5­GGATGCATTCATGAGTATTGC­3; Ifng reverse, 5­CCT­
TTTCCGCTTCCTGAGG­3;  L32  forward,  5­GAAACTGGCGGAA­
ACCCA­3; L32 reverse, 5­GGATCTGGCCCTTGAACCTT­3; V14 
forward,  5­CTAAGCACAGCACGCTGCACA­3;  and  J18  reverse, 
5­CAGGTATGACAATCAGCTGAGTCC­3.
Statistical analyses. All calculations of statistical significance were deter­
mined using a paired Student’s t test. When multiple samples of the same 
genotype were determined in the same experiment, the arithmetic mean of 
those samples was used for the paired t test.
Online supplemental material. Fig. S1 shows that CD8 expression has no 
effect on the avidity of V14i NKT hybridomas for CD1d tetramers. Fig. S2 
shows CD8 and CD4 expression levels by V14i NKT cells and conven­
tional T lymphocytes from the thymus and liver of CD8 Tg/+ and WT   
littermates. Fig. S3 shows CD1d tetramer binding by V14i NKT thymo­
cytes from CD8 Tg and nontransgenic littermates. Fig. S4 depicts the effect 
of the CD8 transgene on V14i NKT cell V usage. Fig. S5 shows that the 
CD8 transgene acts to lower CD1d expression in DP thymocytes. Fig. S6 
shows that CD8 Tg thymocytes have reduced survival in vitro and an altered 
phenotype. Fig. S7 shows that the reduced response of hd/hd V14i NKT 
cells to GalCer is not restricted to the CD8­expressing subset.
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